Measurement of LDL-Cholesterol in Serum by New Enzymatic Method

Authors

  • Surapon Tangvarasittichai Faculty of Allied Health Science, Naresuan University
  • Prawit Taytiwat Health Science Research Institute, Naresuan University

Keywords:

LDL-Cholesterol, Serum, Enzymatic Method

Abstract

Low density Lipoprotein (LDL) plays a key role in causing and influencing the progression of atherosclerosis and coronary sclerosis in particular. The LDLs are derived from Very Low Density Lipoproteins (VLDLs). The elimination of LDL from plasma takes place mainly by the liver parenchymal cells via specific LDL receptors. The LDL-cholesterol value is the most powerful clinical predictor among all of the individual parameters with respect to coronary atherosclerosis. Therefore, therapies focusing on lipid reduction primarily target the reduction of LDL-cholesterol which is then expressed in prevention of atherosclerosis. This new enzymatic automated method for direct determination of LDL-cholesterol in serum had good precision and accuracy. Reproducibility was determined daily using control precinorm® L in an internal protocol (n = 20), within-run CV = 0.856%, and between-run CV = 2.6%. The comparison of the LDL-C level by enzymatic assayed with the calculated LDL-C using the HDL-C determination by enzymatic assayed and by precipitation, showed a good correlation (r = 0.989, Y = 0.966X - 7.255, n = 188 and r = 0.977, Y = 0.957X - 7.049, n = 188). The normal range of LDL-C concentration in serum by this enzymatic method was 57.47 - 221.39 mg/dl. Thus, a normal level of LDL-C should be < 200 mg/dl for good warning. A level > 200 mg/dl warns the doctors that the patient has a high risk of coronary atherosclerosis.

Published

24-08-2020

How to Cite

Tangvarasittichai, S. ., & Taytiwat, P. . (2020). Measurement of LDL-Cholesterol in Serum by New Enzymatic Method. Siriraj Medical Journal, 53(6), 356–362. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/244651

Issue

Vol. 53 No. 6 (2001): June

Section

Original Article

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.